Perioperative chemoimmunotherapy induces strong immune responses and long-term survival in patients with HLA class I-deficient non-small cell lung cancer - Molina-Alejandre M; Perea F; Calvo V; Martinez-Toledo C; Nadal E; Sierra-Rodero B; Casarrubios M; Casal-Rubio J; Martinez-Martí A; Insa A; Massuti B; Viteri S; et al. (Journal for ImmunoTherapy of Cancer, 2024)